Barbara Clayman

1.1k total citations
15 papers, 893 citations indexed

About

Barbara Clayman is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, Barbara Clayman has authored 15 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Barbara Clayman's work include Cervical Cancer and HPV Research (10 papers), Hepatitis B Virus Studies (7 papers) and Virus-based gene therapy research (5 papers). Barbara Clayman is often cited by papers focused on Cervical Cancer and HPV Research (10 papers), Hepatitis B Virus Studies (7 papers) and Virus-based gene therapy research (5 papers). Barbara Clayman collaborates with scholars based in United States, Costa Rica and Norway. Barbara Clayman's co-authors include Raphael P. Viscidi, Robert D. Burk, Mark Schiffman, K. V. Shah, Keerti V. Shah, Rolando Herrero, M. Concepción Bratti, Sophia Wang, Allan Hildesheim and Philip E. Castle and has published in prestigious journals such as The Journal of Infectious Diseases, British Journal of Cancer and Cancer Epidemiology Biomarkers & Prevention.

In The Last Decade

Barbara Clayman

15 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Clayman United States	13	640	341	269	116	112	15	893
Gregory C. Wipf United States	12	675 1.1×	192 0.6×	232 0.9×	207 1.8×	68 0.6×	13	917
Keerti V. Shah United States	13	871 1.4×	404 1.2×	274 1.0×	209 1.8×	35 0.3×	16	1.2k
Judith M. J. E. Bakkers Netherlands	16	535 0.8×	222 0.7×	111 0.4×	48 0.4×	46 0.4×	23	826
Helena Faust Sweden	14	421 0.7×	126 0.4×	103 0.4×	121 1.0×	36 0.3×	28	534
Johanna Ekström Sweden	12	409 0.6×	95 0.3×	155 0.6×	26 0.2×	34 0.3×	14	541
José Carlos Mann Prado United States	7	401 0.6×	196 0.6×	111 0.4×	40 0.3×	30 0.3×	8	503
Klaus Zumbach Germany	10	425 0.7×	118 0.3×	112 0.4×	168 1.4×	17 0.2×	10	576
Karolina Louvanto Finland	18	918 1.4×	358 1.0×	176 0.7×	93 0.8×	14 0.1×	51	1.1k
Daniela Höfler Germany	10	282 0.4×	189 0.6×	159 0.6×	72 0.6×	13 0.1×	21	591
Valentina Militello Italy	11	259 0.4×	80 0.2×	79 0.3×	33 0.3×	39 0.3×	14	607

Countries citing papers authored by Barbara Clayman

Since Specialization

Citations

This map shows the geographic impact of Barbara Clayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Clayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Clayman more than expected).

Fields of papers citing papers by Barbara Clayman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Clayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Clayman. The network helps show where Barbara Clayman may publish in the future.

Co-authorship network of co-authors of Barbara Clayman

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Clayman. A scholar is included among the top collaborators of Barbara Clayman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Clayman. Barbara Clayman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Viscidi, Raphael P. & Barbara Clayman. (2007). Serological Cross Reactivity between Polyomavirus Capsids. Advances in experimental medicine and biology. 577. 73–84. 55 indexed citations

Viscidi, Raphael P., Bradley S. Snyder, Susan Cu‐Uvin, et al.. (2005). Human Papillomavirus Capsid Antibody Response to Natural Infection and Risk of Subsequent HPV Infection in HIV-Positive and HIV-Negative Women. Cancer Epidemiology Biomarkers & Prevention. 14(1). 283–288. 67 indexed citations

Wang, Sophia, Mark Schiffman, Rolando Herrero, et al.. (2004). Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. British Journal of Cancer. 91(7). 1269–1274. 61 indexed citations

Viscidi, Raphael P., Mark Schiffman, Allan Hildesheim, et al.. (2004). Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection. Cancer Epidemiology Biomarkers & Prevention. 13(2). 324–327. 145 indexed citations

Wang, Sophia, Mark Schiffman, Tammy S. Shields, et al.. (2003). Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica. British Journal of Cancer. 89(7). 1248–1254. 107 indexed citations

Viscidi, Raphael P., Barbara Clayman, L. Stewart Massad, et al.. (2003). Serum Immunoglobulin A Response to Human Papillomavirus Type 16 Virus–Like Particles in Human Immunodeficiency Virus (HIV)–Positive and High‐Risk HIV–Negative Women. The Journal of Infectious Diseases. 188(12). 1834–1844. 55 indexed citations

Viscidi, Raphael P., Barbara Clayman, L. Stewart Massad, et al.. (2003). Serum Immunoglobulin G Response to Human Papillomavirus Type 16 Virus‐Like Particles in Human Immunodeficiency Virus (HIV)–Positive and Risk‐Matched HIV‐Negative Women. The Journal of Infectious Diseases. 187(2). 194–205. 48 indexed citations

Viscidi, Raphael P., Dana E. Rollison, Barbara Clayman, et al.. (2003). Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays. Clinical and Vaccine Immunology. 10(2). 278–285. 119 indexed citations

Sun, Yeping, José Eluf‐Neto, F. Xavier Bosch, et al.. (1999). Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.. PubMed. 8(10). 935–40. 30 indexed citations

10.

Strickler, Howard D., Raphael P. Viscidi, Carlos Escoffery, et al.. (1999). Adeno-associated virus and development of cervical neoplasia. Journal of Medical Virology. 59(1). 60–65. 27 indexed citations

11.

Strickler, Howard D., Mark Schiffman, K. V. Shah, et al.. (1998). A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. European Journal of Cancer Prevention. 7(4). 305–313. 73 indexed citations

12.

Lambert, John S., Raphael P. Viscidi, Mary Clare Walker, et al.. (1997). Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group. Clinical and Diagnostic Laboratory Immunology. 4(3). 302–308. 2 indexed citations

13.

Viscidi, Raphael P., Karen L. Kotloff, Barbara Clayman, et al.. (1997). Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clinical and Diagnostic Laboratory Immunology. 4(2). 122–126. 88 indexed citations

14.

Kinney, Janet S., James H. Conway, Margaret W. Hilgartner, et al.. (1991). Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients. American Journal of Hematology. 36(1). 35–41. 1 indexed citations

15.

Viscidi, Raphael P., Edward F. Ellerbeck, Leslie Garrison, et al.. (1990). Characterization of Serum Antibody Responses to Recombinant HIV-1 gp160 Vaccine by Enzyme Immunoassay. AIDS Research and Human Retroviruses. 6(11). 1251–1256. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact